Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection.

Wiersinga, Willem Joost

Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Feb 2012 - 447-8 p. digital

Publication Type: Case Reports; Letter

1537-6591

10.1093/cid/cir711 doi


Adult
Amines--therapeutic use
Anti-HIV Agents--therapeutic use
Anti-Inflammatory Agents--therapeutic use
Cyclohexanecarboxylic Acids--therapeutic use
Excitatory Amino Acid Antagonists--therapeutic use
Female
Gabapentin
HIV Infections--complications
HIV-1
Humans
Immunoglobulins, Intravenous--therapeutic use
Opsoclonus-Myoclonus Syndrome--etiology
Prednisolone--therapeutic use
RNA, Viral--blood
Treatment Failure
gamma-Aminobutyric Acid--therapeutic use